Meganathan Kannan
- Hematology top 2%
- Platelet Disorders and Treatments 29
- Blood Coagulation and Thrombosis Mechanisms 16
- Blood groups and transfusion 13
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management 14
- Genetics top 5%
- Blood disorders and treatments 7
- Myeloproliferative Neoplasms: Diagnosis and Treatment 7
- Hepatology top 10%
-
- Heparin-Induced Thrombocytopenia and Thrombosis 10
-
- COVID-19 Clinical Research Studies 6
- Co-authors
- Firdos AhmadRenu SaxenaChintamani D. AtreyaRafeeq AhmedMaitreyee BhattacharyyaPawan GuptaV. P. ChoudhrySandhya Kulkarni
- Cited by
- HematologyInternal MedicineGenetics
- Partner nations
- IndiaUnited StatesUnited Arab Emirates
In The Last Decade
Meganathan Kannan
73 papers receiving 980 citations
Peers
Comparison fields: 5 of 99
- Hematology 468
- Internal Medicine 115
- Genetics 162
- Hepatology 93
- Cancer Research 89
Countries citing papers authored by Meganathan Kannan
This map shows the geographic impact of Meganathan Kannan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meganathan Kannan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meganathan Kannan more than expected).
Fields of papers citing papers by Meganathan Kannan
This network shows the impact of papers produced by Meganathan Kannan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meganathan Kannan. The network helps show where Meganathan Kannan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meganathan Kannan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 25 | |
| 7 | 2020 | 0 | |
| 8 | 2019 | 12 | |
| 9 | 2019 | 60 | |
| 10 | Prevalence of H. pylori Infection in Type 2 Diabetes mellitus patients in Rural Rajasthan – A Case Control Study | 2014 | 3 |
| 11 | 2009 | 2 | |
| 12 | 2009 | 10 | |
| 13 | Diagnostic strategy in heparin induced thrombocytopenia | 2009 | 1 |
| 14 | 2008 | 7 | |
| 15 | 2007 | 23 | |
| 16 | 2006 | 27 | |
| 17 | 2005 | 3 | |
| 18 | 2004 | 10 | |
| 19 | 2003 | 3 | |
| 20 | 2003 | 17 |
About Meganathan Kannan
Meganathan Kannan is a scholar working on Hematology, Internal Medicine, Genetics, Emergency Medicine and Immunology and Allergy, having authored 76 papers that have together received 1.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (29 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers), Venous Thromboembolism Diagnosis and Management (14 papers), Blood groups and transfusion (13 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers), Blood disorders and treatments (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and COVID-19 Clinical Research Studies (6 papers). The work is most often cited by research in Hematology (468 citations), Internal Medicine (115 citations), Genetics (162 citations), Hepatology (93 citations) and Cancer Research (89 citations). Meganathan Kannan has collaborated with scholars based in India, United States and United Arab Emirates. Frequent co-authors include Firdos Ahmad, Renu Saxena, Renu Saxena, Chintamani D. Atreya, Rafeeq Ahmed, Maitreyee Bhattacharyya, Pawan Gupta, V. P. Choudhry, Sandhya Kulkarni and Rabih Halwani. Their work appears in journals such as Annals of Hematology, Blood, Thrombosis and Haemostasis, American Journal of Hematology and American Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.